General Information of the Compound
| Compound ID |
CP0082264
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1R,2S,3R,5R)-3-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol
Show/Hide
|
||||||||||||||||||
| Synonyms |
1,2-Cyclopentanediol,5-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)-, (1S,2R,3R,5R)-
19186-33-5
3-(6-amino-9h-purin-9-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol
3-(6-aminopurin-9-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol
AC1L1D83
AC1Q4VH0
ARISTEROMYCIN
CTK4E0829
Carbocyclic Lyxo-A
Carbocyclic Xylo-A
Cyclaradine Carbocyclic Ara A
J-012404
NSC-103526
NSC-613806
NSC-613807
NSC-615828
NSC103526
NSC613806
NSC613807
NSC615828
SCHEMBL9820408
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H15N5O3
|
||||||||||||||||||
| Molecular Weight |
265.273
|
||||||||||||||||||
| Canonical SMILES |
Nc1ncnc2n(cnc12)[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H15N5O3/c12-10-7-11(14-3-13-10)16(4-15-7)6-1-5(2-17)8(18)9(6)19/h3-6,8-9,17-19H,1-2H2,(H2,12,13,14)/t5-,6-,8-,9+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UGRNVLGKAGREKS-GCXDCGAKSA-N
|
||||||||||||||||||
| CAS |
19186-33-5
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound